Sanofi-Aventis CR`s Shareholders' Equity Growth reached 1.79 % in 2017. This is 68.59999999999999 % less than in the previous year.
Buy Shareholders' Equity Growth data for Sanofi-Aventis Czech Republic.
$19.99Buy all data for Sanofi-Aventis Czech Republic.
Buy annual subscriptions for all our products.
| Company | Unit | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
| Amgen Czech Republic | % | ... | ... | ... | ... | ... | 37.5 | 16.7 | -15.8 | 24.3 | -11.7 | |||||||
| Bayer Czech Republic | % | ... | ... | ... | -6.69 | -37.1 | -1.31 | -15.1 | 1.44 | |||||||||
| GlaxoSmithKline Czech Republic | % | ... | ... | ... | 21.4 | 0.377 | -2.06 | -2.90 | 2.83 | |||||||||
| Merck Czech Republic | % | ... | ... | 28.0 | 28.2 | 9.48 | 11.0 | 19.6 | ||||||||||
| Novartis Czech Republic | % | 21.3 | 22.7 | 16.5 | 24.2 | 19.6 | ||||||||||||
| Pfizer Czech Republic | % | ... | ... | 28.8 | 0.865 | 49.8 | 8.56 | -30.5 | ||||||||||
| Roche Czech Republic | % | ... | ... | ... | 4.97 | 3.63 | 12.2 | -8.48 | 4.50 | ... | ||||||||
| Sanofi-Aventis Czech Republic | % | ... | ... | ... | ... | 11.6 | 8.56 | 11.4 | 0.186 | 9.16 | ||||||||
| Servier Czech Republic | % | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | ... | 40.9 | 29.1 | 24.6 | ||
| Walmark | % | ... | ... | ... | 15.5 | -69.9 | 73.1 | 4.72 | -113 |
Helgi Library 
